Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
Go back to Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026| (NASDAQ: ACRS) | Delayed: 4.84 +0.34 (7.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $33.88 | |||
| Open | $4.55 | 52 Week Low | $14.12 | |||
| Day High | $4.93 | P/E | N/A | |||
| Day Low | $4.50 | EPS | $0.00 | |||
| Volume | 1,819,281 | |||||
